176 related articles for article (PubMed ID: 17109449)
1. Estimation of the optimal brachytherapy utilization rate in the treatment of carcinoma of the uterine cervix: review of clinical practice guidelines and primary evidence.
Thompson S; Delaney G; Gabriel GS; Jacob S; Das P; Barton M
Cancer; 2006 Dec; 107(12):2932-41. PubMed ID: 17109449
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the optimal brachytherapy utilization rate in the treatment of gynecological cancers and comparison with patterns of care.
Thompson SR; Delaney GP; Gabriel GS; Jacob S; Das P; Barton MB
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):400-5. PubMed ID: 22658439
[TBL] [Abstract][Full Text] [Related]
3. Estimation of optimal brachytherapy utilization rate in the treatment of malignancies of the uterine corpus by a review of clinical practice guidelines and the primary evidence.
Thompson SR; Delaney G; Gabriel GS; Jacob S; Das P; Barton M
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):849-58. PubMed ID: 18448273
[TBL] [Abstract][Full Text] [Related]
4. Estimation of the optimal brachytherapy utilisation rate in the treatment of vaginal cancer and comparison with patterns of care.
Thompson SR; Delaney GP; Gabriel GS; Jacob S; Barton MB
J Med Imaging Radiat Oncol; 2012 Aug; 56(4):483-9. PubMed ID: 22883660
[TBL] [Abstract][Full Text] [Related]
5. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I--malignancies of the cervix, ovary, vagina and vulva.
Delaney G; Jacob S; Barton M
Cancer; 2004 Aug; 101(4):671-81. PubMed ID: 15305396
[TBL] [Abstract][Full Text] [Related]
6. Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma.
Delaney G; Jacob S; Barton M
Cancer; 2005 Jun; 103(11):2216-27. PubMed ID: 15856428
[TBL] [Abstract][Full Text] [Related]
7. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part II--carcinoma of the endometrium.
Delaney G; Jacob S; Barton M
Cancer; 2004 Aug; 101(4):682-92. PubMed ID: 15305397
[TBL] [Abstract][Full Text] [Related]
8. Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: a review of the evidence.
Delaney G; Barton M; Jacob S
Cancer; 2004 Aug; 101(4):657-70. PubMed ID: 15305395
[TBL] [Abstract][Full Text] [Related]
9. Estimating the optimal radiotherapy utilization for carcinoma of the central nervous system, thyroid carcinoma, and carcinoma of unknown primary origin from evidence-based clinical guidelines.
Delaney G; Jacob S; Barton M
Cancer; 2006 Jan; 106(2):453-65. PubMed ID: 16355366
[TBL] [Abstract][Full Text] [Related]
10. Estimation of an optimal radiotherapy utilization rate for breast carcinoma: a review of the evidence.
Delaney G; Barton M; Jacob S
Cancer; 2003 Nov; 98(9):1977-86. PubMed ID: 14584082
[TBL] [Abstract][Full Text] [Related]
11. Estimation of an optimal chemotherapy utilisation rate for head and neck carcinoma: setting an evidence-based benchmark for the best-quality cancer care.
Ng W; Jacob S; Delaney G; Barton M
Eur J Cancer; 2009 Aug; 45(12):2150-9. PubMed ID: 19285857
[TBL] [Abstract][Full Text] [Related]
12. Establishing treatment benchmarks for mammography-screened breast cancer population based on a review of evidence-based clinical guidelines.
Delaney G; Shafiq J; Chappell G; Barton M
Cancer; 2008 May; 112(9):1912-22. PubMed ID: 18318431
[TBL] [Abstract][Full Text] [Related]
13. Estimation of an optimal radiotherapy utilization rate for melanoma: a review of the evidence.
Delaney G; Barton M; Jacob S
Cancer; 2004 Mar; 100(6):1293-301. PubMed ID: 15022299
[TBL] [Abstract][Full Text] [Related]
14. Patterns of care and outcome in elderly cervical cancer patients: a special focus on brachytherapy.
Magné N; Mancy NC; Chajon E; Duvillard P; Pautier P; Castaigne D; Lhommé C; Morice P; Haie-Meder C
Radiother Oncol; 2009 May; 91(2):197-201. PubMed ID: 18954913
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : correlation of radiologic findings with surgicopathologic results.
Vincens E; Balleyguier C; Rey A; Uzan C; Zareski E; Gouy S; Pautier P; Duvillard P; Haie-Meder C; Morice P
Cancer; 2008 Oct; 113(8):2158-65. PubMed ID: 18780318
[TBL] [Abstract][Full Text] [Related]
16. Estimation of the optimal utilisation rates of radical prostatectomy, external beam radiotherapy and brachytherapy in the treatment of prostate cancer by a review of clinical practice guidelines.
Thompson SR; Delaney GP; Jacob S; Shafiq J; Wong K; Hanna TP; Gabriel GS; Barton MB
Radiother Oncol; 2016 Jan; 118(1):118-21. PubMed ID: 26776443
[TBL] [Abstract][Full Text] [Related]
17. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines.
Delaney G; Jacob S; Featherstone C; Barton M
Cancer; 2005 Sep; 104(6):1129-37. PubMed ID: 16080176
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix.
Zwahlen D; Jezioranski J; Chan P; Haider MA; Cho YB; Yeung I; Levin W; Manchul L; Fyles A; Milosevic M
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1157-64. PubMed ID: 19101097
[TBL] [Abstract][Full Text] [Related]
19. Clinical results of medium dose rate brachytherapy combined with external beam radiotherapy in the treatment of advanced cervical carcinoma.
Ordeanu C; Coza O; Gavris S; Todor N; Szilagy E; Bako M; Cernea V; Ghilezan N; Nagy V
J BUON; 2007; 12(2):221-6. PubMed ID: 17600876
[TBL] [Abstract][Full Text] [Related]
20. Estimation of an optimal chemotherapy utilisation rate for colon cancer: an evidence-based benchmark for cancer care.
Jacob S; Ng W; Asghari R; Delaney GP; Barton MB
Eur J Cancer; 2009 Sep; 45(14):2503-9. PubMed ID: 19527926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
